Fund Holdings
As on 31-May-2013
| Asset Type | Instrument Name | Industry | Net Assets (%) | No of Shares | Mkt Value (Cr.) | | Equity & Equity related Investments | | Equity | divi's laboratories ltd | Pharmaceuticals | 11.0 | 700,000 | 75.2 | | Equity | ranbaxy laboratories ltd | Pharmaceuticals | 9.2 | 1,400,000 | 63.3 | | Equity | sanofi india ltd | Pharmaceuticals | 9.2 | 245,810 | 62.8 | | Equity | cipla ltd | Pharmaceuticals | 9.0 | 1,523,439 | 61.7 | | Equity | dr. reddy's laboratories ltd | Pharmaceuticals | 8.4 | 285,100 | 57.8 | | Equity | sun pharma advanced research company ltd | Miscellaneous | 7.1 | 3,906,291 | 48.5 | | Equity | sun pharmaceuticals industries ltd | Pharmaceuticals | 6.9 | 500,000 | 47.6 | | Equity | glaxosmithkline pharmaceuticals ltd | Pharmaceuticals | 6.2 | 187,900 | 42.5 | | Equity | indoco remedies ltd | Pharmaceuticals | 5.3 | 5,754,278 | 36.3 | | Equity | abbott india ltd | Pharmaceuticals | 4.5 | 219,550 | 30.9 | | Equity | ipca laboratories ltd | Pharmaceuticals | 4.5 | 600,319 | 30.5 | | Equity | zydus wellness ltd | FMCG | 3.6 | 560,645 | 24.9 | | Equity | cadila healthcare ltd | Pharmaceuticals | 3.4 | 300,351 | 23.6 | | Equity | biocon ltd | Pharmaceuticals | 3.4 | 800,000 | 23.0 | | Equity | glenmark pharmaceuticals ltd | Pharmaceuticals | 2.5 | 350,000 | 17.0 | | Equity | fulford india ltd | Pharmaceuticals | 1.0 | 110,901 | 7.1 | | Equity | lupin ltd | Pharmaceuticals | 0.9 | 90,000 | 6.3 | | Equity | merck ltd | Pharmaceuticals | 0.9 | 96,696 | 6.1 | | Equity | unichem laboratories ltd | Pharmaceuticals | 0.7 | 289,574 | 4.9 | | Equity | vimta labs ltd | Miscellaneous | 0.1 | 310,313 | 0.6 | | Debt Investments | | NCD | dr. reddy's laboratories ltd | AA+ | 0.0 | 318,600 | 0.2 | | Cash & Cash Equivalent | | CBLO | cblo | UR / N.A. | 2.4 | NA | 16.3 | | Net CA & Others | net current assets | -/- | [0.4] | NA | [2.4] |
|

|